Willmore E; de Caux S; Sunter NJ; et al. (2004). „A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia”. Blood. 103 (12): 4659—65. PMID15010369. doi:10.1182/blood-2003-07-2527.CS1 одржавање: Експлицитна употреба et al. (веза)
Willmore E; de Caux S; Sunter NJ; et al. (2004). „A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia”. Blood. 103 (12): 4659—65. PMID15010369. doi:10.1182/blood-2003-07-2527.CS1 одржавање: Експлицитна употреба et al. (веза)